A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Clinical trial NCT04809220 · COMPLETED

Trial details

NCT number: NCT04809220
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Disease Endocrine System Diseases Hypoglycemic Agents Type 2 Diabetes Mellitus (T2DM)

Start date: 2021-04-13
Primary completion: 2022-10-01
Enrollment: 591

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.